Outset Medical Inc (OM) - Total Assets
Based on the latest financial reports, Outset Medical Inc (OM) holds total assets worth $249.45 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Outset Medical Inc (OM) net asset quality to measure how much of total assets are equity-financed.
Outset Medical Inc - Total Assets Trend (2018–2025)
This chart illustrates how Outset Medical Inc's total assets have evolved over time, based on quarterly financial data. Check OM goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Outset Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Outset Medical Inc's total assets of $249.45 Million consist of 94.9% current assets and 5.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.2% |
| Accounts Receivable | $28.33 Million | 10.7% |
| Inventory | $47.61 Million | 18.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Outset Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see OM market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Outset Medical Inc's current assets represent 94.9% of total assets in 2025, a decrease from 97.7% in 2018.
- Cash Position: Cash and equivalents constituted 13.2% of total assets in 2025, down from 22.0% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is inventory at 18.0% of total assets.
Outset Medical Inc Competitors by Total Assets
Key competitors of Outset Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
Outset Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.29 | 8.37 | 12.64 |
| Quick Ratio | 4.97 | 6.74 | 11.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $199.10 Million | $252.34 Million | $412.52 Million |
Outset Medical Inc - Advanced Valuation Insights
This section examines the relationship between Outset Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.61 |
| Latest Market Cap to Assets Ratio | 0.26 |
| Asset Growth Rate (YoY) | -4.1% |
| Total Assets | $264.50 Million |
| Market Capitalization | $67.66 Million USD |
Valuation Analysis
Below Book Valuation: The market values Outset Medical Inc's assets below their book value (0.26x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Outset Medical Inc's assets decreased by 4.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Outset Medical Inc (2018–2025)
The table below shows the annual total assets of Outset Medical Inc from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $264.50 Million | -4.10% |
| 2024-12-31 | $275.80 Million | -12.11% |
| 2023-12-31 | $313.80 Million | -21.57% |
| 2022-12-31 | $400.12 Million | -13.67% |
| 2021-12-31 | $463.46 Million | +14.77% |
| 2020-12-31 | $403.83 Million | +357.00% |
| 2019-12-31 | $88.37 Million | -41.53% |
| 2018-12-31 | $151.13 Million | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more